Galectin-3-ITGB1 Signaling Mediates Interleukin 10 Production of Hepatic Conventional Natural Killer Cells in Hepatitis B Virus Transgenic Mice and Correlates with Hepatocellular Carcinoma Progression in Patients
Viruses · 2024-05-07 · 16 (5) · 737
DOI: 10.3390/v16050737 ↗At a glance
Journal article in Viruses, published online on 2024-05-07. Written by Yongyan Chen and 6 co-authors. Institution: Key Laboratory of Immune Response and Immunotherapy, Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for…. Major MEDLINE topics: Carcinoma, Hepatocellular, Hepatitis B virus, Interleukin-10, Killer Cells, Natural. Cited 9 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key R& D Program of China ; Natural Science Foundation of China, National Key R& D Program of China, Natural Science Foundation of China.
Abstract (original language)
Background and Aims: The outcomes of HBV infections are related to complex immune imbalances; however, the precise mechanisms by which HBV induces immune dysfunction are not well understood.
Methods
HBV transgenic (HBs-Tg) mice were used to investigate intrahepatic NK cells in two distinct subsets: conventional NK (cNK) and liver-resident NK (LrNK) cells during a chronic HBV infection.
Results
The cNK cells, but not the LrNK cells, were primarily responsible for the increase in the number of bulk NK cells in the livers of ageing HBs-Tg mice. The hepatic cNK cells showed a stronger ability to produce IL-10, coupled with a higher expression of CD69, TIGIT and PD-L1, and lower NKG2D expression in ageing HBs-Tg mice. A lower mitochondrial mass and membrane potential, and less polarized localization were observed in the hepatic cNK cells compared with the splenic cNK cells in the HBs-Tg mice. The enhanced galectin-3 (Gal-3) secreted from HBsAg+ hepatocytes accounted for the IL-10 production of hepatic cNK cells via ITGB1 signaling. For humans, LGALS3 and ITGB1 expression is positively correlated with IL-10 expression, and negatively correlated with the poor clinical progression of HCC.
Conclusions
Gal-3-ITGB1 signaling shapes hepatic cNK cells but not LrNK cells during a chronic HBV infection, which may correlate with HCC progression.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Key Laboratory of Immune Response and Immunotherapy, Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of…
- Research Unit of NK Cell Study, Chinese Academy of Medical Sciences, Hefei 230027, China.
- Department of Geriatrics, Gerontology Institute of Anhui Province, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.
Funding
- National Key R& D Program of China ; Natural Science Foundation of China
- National Key R& D Program of China
- Natural Science Foundation of China
- Chinese Academy of Science
Cite
APA
Chen, Y., Zhang, W., Cheng, M., Hao, X., Wei, H., Sun, R., & Tian, Z. (2024). Galectin-3-ITGB1 Signaling Mediates Interleukin 10 Production of Hepatic Conventional Natural Killer Cells in Hepatitis B Virus Transgenic Mice and Correlates with Hepatocellular Carcinoma Progression in Patients. Viruses, 16(5), 737. https://doi.org/10.3390/v16050737
Vancouver
Chen Y, Zhang W, Cheng M, Hao X, Wei H, Sun R, et al. Galectin-3-ITGB1 Signaling Mediates Interleukin 10 Production of Hepatic Conventional Natural Killer Cells in Hepatitis B Virus Transgenic Mice and Correlates with Hepatocellular Carcinoma Progression in Patients. Viruses. 2024;16(5):737. doi:10.3390/v16050737
BibTeX
@article{Chen2024,
author = {Chen, Yongyan and Zhang, Wendi and Cheng, Min and Hao, Xiaolei and Wei, Haiming and Sun, Rui and Tian, Zhigang},
title = {Galectin-3-ITGB1 Signaling Mediates Interleukin 10 Production of Hepatic Conventional Natural Killer Cells in Hepatitis B Virus Transgenic Mice and Correlates with Hepatocellular Carcinoma Progression in Patients},
journal = {Viruses},
year = {2024},
volume = {16},
number = {5},
pages = {737},
doi = {10.3390/v16050737}
}
EUVIMED